| Active surveillance: is there a need for better risk stratification at the outset? | |
| | |
MedLine Citation:
|
PMID: 20697073 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Paras B Singh; Hashim U Ahmed; Mark Emberton |
Related Documents
:
|
9343003 - Price of adaptation--allostatic load and its health consequences. macarthur studies of ... 11920403 - Risk factors for total hip replacement due to primary osteoarthritis: a cohort study in... 17030233 - Preterm delivery and asthma: a systematic review and meta-analysis. |
Publication Detail:
|
Type: Comment; Letter Date: 2010-08-09 |
Journal Detail:
|
Title: Journal of clinical oncology : official journal of the American Society of Clinical Oncology Volume: 28 ISSN: 1527-7755 ISO Abbreviation: J. Clin. Oncol. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-30 Completed Date: 2010-11-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8309333 Medline TA: J Clin Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: e513; author reply e514 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Disease Progression Humans Male Population Surveillance* Prostate-Specific Antigen / blood Prostatic Neoplasms / blood, mortality*, surgery Risk Assessment |
| Chemical | |
Reg. No./Substance:
|
EC 3.4.21.77/Prostate-Specific Antigen |
| Comments/Corrections | |
Comment On:
|
J Clin Oncol. 2010 Jan 1;28(1):126-31
[PMID:
19917860
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sezary Syndrom...
Next Document: Technology Evolution: Is it Survival of the Fittest?